Related Experiment Video

Updated: Mar 31, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

12.1K

[Differntial diagnosis of neuromyelitis optica]

Kazuhide Ochi, Tatsuo Kohriyama, Masayasu Matsumoto

    Nihon Rinsho. Japanese Journal of Clinical Medicine
    |October 21, 2015
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
    05:45

    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

    Published on: April 5, 2019

    24.3K
    Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
    12:23

    Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

    Published on: April 14, 2014

    14.7K

    Related Experiment Videos

    Last Updated: Mar 31, 2026

    Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
    09:29

    Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

    Published on: August 21, 2017

    12.1K
    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay
    05:45

    Human Serum Anti-aquaporin-4 Immunoglobulin G Detection by Cell-based Assay

    Published on: April 5, 2019

    24.3K
    Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
    12:23

    Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

    Published on: April 14, 2014

    14.7K

    Related Concept Videos

    Myasthenia Gravis: Diagnostic Tests01:15

    Myasthenia Gravis: Diagnostic Tests

    3.1K
    Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
    The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
    3.1K
    Myasthenia Gravis: Overview and Treatment01:20

    Myasthenia Gravis: Overview and Treatment

    3.4K
    Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
    These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
    3.4K

    Articles linked to this work by shared authors, journal, and citation graph.

    Real-world timing of early anticoagulation therapy in intracerebral hemorrhage patients with atrial fibrillation: An observational study.

    Journal of the neurological sciences·2026

    Ultrasonographic Reference Values of the Brachial Plexus Cross-Sectional Area in Healthy Japanese Adults.

    Muscle & nerve·2025

    The periodontal pathogen Fusobacterium nucleatum is associated with disease severity in multiple sclerosis.

    Scientific reports·2025

    Indicators associated with outcomes of in-hospital ischemic stroke.

    Clinical neurology and neurosurgery·2025

    Comparison of prednisolone monotherapy vs. tacrolimus combination in NMOSD: Efficacy, safety, and optimal therapeutic timing.

    Journal of neuroimmunology·2025

    [Rehabilitation therapy for aquaporin-4 antibody positive neuromyelitis optica spectrum disorders].

    Rinsho shinkeigaku = Clinical neurology·2024
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us